(1)
STEPHY.T.P; SREEJITH. K; Dr. BINDU G. Comparison of Quality of Life (QOL) for Patients With Breast Cancer Receiving Adjuvant Tac (docetaxel, Doxorubicin, Cyclophosphamide) and Fac (5-Fluorouracil, Doxorubicin, Cyclophosphamide) Therapy. ijpbs 2017, 8, 373-382.